✦ LIBER ✦

Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range

✍ Scribed by Craig H. Mallinckrodt; Apurva Prakash; Anne C. Andorn; John G. Watkin; Madelaine M. Wohlreich

Book ID: 113750069
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 180 KB
Volume: 40
Category: Article
ISSN: 0022-3956
DOI: 10.1016/j.jpsychires.2005.08.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duloxetine for the treatment of major de

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

✍ Madelaine M. Wohlreich; Craig H. Mallinckrodt; Apurva Prakash; John G. Watkin; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

P.1.160 Duloxetine for the treatment of

P.1.160 Duloxetine for the treatment of major depressive disorder: Safety and efficacy associated with rapid dose escalation (60–120 mg QD)

✍ M. Wohlreich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

P.4.a.006 A fixed dose study of the effi

P.4.a.006 A fixed dose study of the efficacy and safety of duloxetine for the treatment of generalised anxiety disorder

✍ H. Koponen; C. Allgulander; Y.L. Pritchett; J. Erickson; M.J. Detke; S. Ball; J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Efficacy and safety of duloxetine for tr

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

✍ I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB

P.2.c.021 Levomilnacipran in the treatme

P.2.c.021 Levomilnacipran in the treatment of major depressive disorder: an analysis of efficacy and safety data from two phase III studies

✍ W. Greenberg; C. Gommoll; A. Bose; H. Li; A. Ruth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Vilazodone for major depressive disorder

Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

✍ L. Citrome 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB